Kang YU
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors (NCT03302403) | Kang YU | 2017-12-29 |
Track Kang YU automatically
Every clearance here is in the API, with alerts when new ones post.